Identification and validation of serum autoantibodies in children with B-cell acute lymphoblastic leukemia by serological proteome analysis

BACKGROUND: B-cell acute lymphoblastic leukemia (B-ALL) is the most common malignancy of childhood. Even though significant progresses have been made in the treatment of B-ALL, some pediatric B-ALL have still poor prognosis. The identification of tumor autoantibodies may have utility in early cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Runhong, Yang, Shiwei, Liu, Yufeng, Zhu, Zunmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808998/
https://www.ncbi.nlm.nih.gov/pubmed/35109855
http://dx.doi.org/10.1186/s12953-021-00184-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808998/
https://www.ncbi.nlm.nih.gov/pubmed/35109855
http://dx.doi.org/10.1186/s12953-021-00184-w

Ejemplares similares